Rush A J, Schlesser M A, Giles D E, Crowley G T, Fairchild C, Altshuler K Z
Psychiatry Res. 1982 Dec;7(3):277-85. doi: 10.1016/0165-1781(82)90064-6.
A sample of 23 drug-free, normal adult subjects, aged 23 to 50 years, received 1 mg dexamethasone p.o. at midnight. Serum cortisols were obtained at 0800h, 1600h, and 2330h pre- and postdexamethasone. Only 1 of these 23 subjects (4.3%) evidenced nonsuppression, as defined by any postdexamethasone serum cortisol value of greater than 4.0 micrograms/dl. A dose of 0.75 mg dexamethasone was administered to 23 drug-free, normal adult subjects, 20 of whom participated in the above 1 mg trial. Six of these 23 (26.1%) showed nonsuppression at a threshold of 4.0 micrograms/dl. Another 11 normal adults who were taking various prescription medications (e.g., sympathomimetics, nasal decongestants, birth control pills, thyroid hormones) or who were suffering from untreated upper respiratory infections, venereal infections, or allergies were tested with 1 mg of dexamethasone. In this sample, 7 of 13 (53.8%) showed nonsuppression. These findings suggest that: (1) 1 mg of dexamethasone is the lowest effective dose that can be used in diagnostic testing for melancholic depression; (2) a false-positive response to the dexamethasone suppression test (DST) may occur with infections, allergies, or possibly with certain prescription medications. Further studies of the effects of illness and/or medications on DST responses are needed.
选取了23名年龄在23至50岁之间、未服用药物的正常成年受试者,于午夜口服1毫克地塞米松。在服用地塞米松前后的08:00、16:00和23:30采集血清皮质醇。这23名受试者中只有1人(4.3%)出现了未被抑制的情况,定义为服用地塞米松后血清皮质醇值大于4.0微克/分升。给23名未服用药物的正常成年受试者服用0.75毫克地塞米松,其中20人参与了上述1毫克剂量的试验。这23人中的6人(26.1%)在阈值为4.0微克/分升时出现未被抑制的情况。另外11名正在服用各种处方药(如拟交感神经药、鼻减充血剂、避孕药、甲状腺激素)或患有未经治疗的上呼吸道感染、性传播感染或过敏的正常成年人接受了1毫克地塞米松的测试。在这个样本中,13人中有7人(53.8%)出现未被抑制的情况。这些发现表明:(1)1毫克地塞米松是可用于忧郁症诊断测试的最低有效剂量;(2)地塞米松抑制试验(DST)的假阳性反应可能与感染、过敏或可能与某些处方药有关。需要进一步研究疾病和/或药物对DST反应的影响。